What We're Reading: Page 285
Industry reads hand-picked by our editors
Oct 12, 2017
-
MarketWatch
This drug may be able to treat both women’s health disorders and prostate cancer
-
Chicago Tribune
Amazon vs. Walgreens? It's just around the corner
-
Crain's Chicago Business
This U of C startup thinks it can end food allergies
Oct 11, 2017
-
Bloomberg Gadfly
Cancer-drug prices are at a tipping point
-
Scientific American
Could the "Alzheimer's gene" finally become a drug target?
-
TechCrunch
Menlo Ventures dives into data-driven healthcare investing with its newest partner
Oct 10, 2017
Oct 09, 2017
-
The New York Times
As cancer tears through Africa, drug makers draw up a battle plan
-
Bloomberg
Big pharma gets boost as China speeds up new drug approvals
-
BBC
Thalidomide campaigners in talks with German government
-
Business Insider
Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine
Oct 06, 2017
Oct 05, 2017
-
Nikkei Asian Review
Novartis wants Japan to link drug price to patient outcomes
-
Bloomberg Gadfly
Evidence of biotech froth continues to mount
-
Vox
The 2017 Nobel Prize in chemistry, explained in 500 words
-
Financial Times
In-house lawyers are the new pathfinders
Oct 04, 2017
-
Medical Marketing & Media
7 professional paths of 7 pharma execs
-
Bloomberg
Allergan patent deal may hurt competition, lawmakers say
-
Xconomy
Palleon lands $46M to develop new type of checkpoint cancer drug
Previous
